| Tyche Industries Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532384 |
NSE Symbol : - |
P/E(TTM) : 11.57 |
|
ISIN Demat : INE443B01012 |
Div & Yield% : 2.75 |
EPS(TTM) : 9.41 |
|
Book Value(₹) : 137.23 |
Market Cap(₹Cr) : 111.62 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 14.16 | 12.70 | 12.37 | 17.75 | 20.54 | 15.52 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 14.16 | 12.70 | 12.37 | 17.75 | 20.54 | 15.52 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.65 | 1.77 | 2.01 | 2.04 | 1.84 | 1.52 |
| Total Income | 16.81 | 14.46 | 14.37 | 19.79 | 22.38 | 17.04 |
| Total Expenditure | 14.29 | 10.75 | 12.54 | 12.92 | 16.52 | 12.91 |
| PBIDT | 2.52 | 3.71 | 1.83 | 6.88 | 5.86 | 4.14 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 2.52 | 3.71 | 1.83 | 6.87 | 5.86 | 4.14 |
| Depreciation | 0.47 | 0.45 | 0.50 | 0.50 | 0.49 | 0.49 |
| Tax | 0.55 | 0.85 | 0.40 | 1.66 | 1.39 | 0.94 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
| Reported Profit After Tax | 1.52 | 2.43 | 0.94 | 4.74 | 3.99 | 2.73 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | -0.52 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.52 | 2.43 | 0.94 | 4.74 | 4.51 | 2.73 |
| EPS (Unit Curr.) | 1.49 | 2.37 | 1.00 | 4.63 | 3.90 | 2.66 |
| EPS (Adj) (Unit Curr.) | 1.49 | 2.37 | 1.00 | 4.63 | 3.90 | 2.66 |
| Calculated EPS (Unit Curr.) | 1.49 | 2.37 | 0.92 | 4.63 | 3.90 | 2.66 |
| Calculated EPS (Adj) (Unit Curr.) | 1.49 | 2.37 | 0.92 | 4.63 | 3.90 | 2.66 |
| Calculated EPS (Ann.) (Unit Curr.) | 5.95 | 9.49 | 3.69 | 18.52 | 15.60 | 10.64 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 5.95 | 9.49 | 3.69 | 18.52 | 15.60 | 10.64 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 17.80 | 29.21 | 14.79 | 38.76 | 28.53 | 26.68 |
| PBDTM(%) | 17.80 | 29.21 | 14.79 | 38.70 | 28.53 | 26.68 |
| PATM(%) | 10.73 | 19.13 | 7.60 | 26.70 | 19.43 | 17.59 |